Indivior-Supernus Merger Closes; $650M Term Loan Funds $1B Special Dividend
INDV sits 28% above its 52-week low of $27.68 on elevated volume (1.9× avg).
Summary
Indivior and Supernus completed their merger of equals on November 2, 2026, renaming the combined company Supernus, Inc. (SUPN) and drawing a $650 million term loan to help fund the $1.0 billion special dividend.
Key Events · M&A and Partnerships · INDV
-
Merger of Equals Closes
At 8:18 a.m. ET on November 2, 2026, Supernus merged into an Indivior subsidiary; each Supernus share converted into 1.5401 Indivior shares, and Indivior was renamed Supernus, Inc.
-
$650M Term Loan Borrowed at Close
To help fund the $1.0 billion aggregate special dividend, the combined company drew the full $650,000,000 senior secured term loan from Citibank on the Closing Date, with the remainder from cash on hand.
-
Ownership Split 56.5% / 43.5%
On a fully diluted basis, legacy Indivior stockholders own approximately 56.5% of the combined company and former Supernus stockholders approximately 43.5%.
-
New Leverage Covenants
The credit agreement requires a maximum Total Net Leverage Ratio of 3.25x through 2027, stepping to 3.00x, and a minimum Consolidated Interest Coverage Ratio of 3.00x.
Analysis · INDV · Life Sciences
The merger of equals is complete, and the combined company starts life with meaningful secured leverage. Indivior has been renamed Supernus, Inc.; Supernus shareholders received 1.5401 Indivior shares per share, leaving legacy Indivior holders with about 56.5% of the combined company versus 43.5% for former Supernus holders. To fund the previously announced $1.0 billion aggregate special dividend, the combined company borrowed the full $650 million term loan from Citibank on day one, with the balance from cash on hand. The credit agreement carries maximum Total Net Leverage Ratio covenants of 3.25x stepping to 3.00x. At closing, the entire legacy Indivior executive team (CEO, CFO, CCO, CLO) exited with roughly $8.1 million in combined salary continuation and lump-sum payments. Supernus's Jack Khattar takes over as CEO, and a new eight-person board is split evenly between the two companies. Shares trade under SUPN from November 3, 2026.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INDV was trading at $35.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $27.68 to $42.81. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.